KD Tripathi is not in the library. I'll answer all 12 reasoning questions from my knowledge of KD Tripathi's Essentials of Medical Pharmacology, which is exactly what the question pages reference.

1. Atropine produces tachycardia but may cause initial transient bradycardia on parenteral injection. Atropine at low doses preferentially blocks presynaptic M1 autoreceptors on vagal nerve endings, which normally inhibit ACh release. Blocking them transiently increases ACh release, causing bradycardia. At higher doses, postsynaptic M2 blockade on the SA node dominates, producing tachycardia.

2. Atropine is contraindicated in patients with narrow angle glaucoma. Atropine causes mydriasis (pupil dilation) and cycloplegia. In narrow-angle glaucoma, the dilated iris physically blocks the trabecular meshwork, impeding aqueous humor drainage and dangerously raising intraocular pressure.

3. Ipratropium is more effective in COPD than in bronchial asthma. In COPD, increased vagal (cholinergic) tone is the dominant cause of bronchoconstriction, so anticholinergic blockade gives significant relief. In asthma, bronchoconstriction is primarily mediated by inflammatory mediators (histamine, leukotrienes) rather than vagal tone, so anticholinergics are less effective.

4. Tiotropium is preferred over ipratropium for long-term control of COPD. Tiotropium has a much longer duration of action (24 hours) due to its slow dissociation from M3 receptors, allowing once-daily dosing. It also has greater selectivity for M3 receptors (bronchodilation) over M2 receptors. Ipratropium requires dosing 3-4 times daily.

5. Glycopyrrolate is preferred as a pre-anesthetic medication instead of atropine. Glycopyrrolate is a quaternary ammonium compound - it does not cross the blood-brain barrier (BBB), so it avoids CNS side effects (confusion, sedation in elderly). It also causes less tachycardia and has a longer duration of antisecretory action compared to atropine.

6. Tropicamide is preferred over atropine for refraction testing in adults. Tropicamide has a much shorter duration of action (6-8 hours vs 7-10 days for atropine). This is sufficient for refraction testing and allows faster recovery of accommodation, making it more practical for outpatient use.

7. Atropine is used as an antidote in organophosphate poisoning. Organophosphates irreversibly inhibit acetylcholinesterase, causing accumulation of ACh and overstimulation of muscarinic receptors (SLUDGE effects). Atropine competitively blocks muscarinic receptors, reversing these effects. It does not act on nicotinic receptors (where pralidoxime is needed).

8. Anticholinergic side effects are more pronounced when combined with tricyclic antidepressants (TCAs) or antihistamines. TCAs (e.g., amitriptyline) and first-generation antihistamines (e.g., promethazine) themselves have significant anticholinergic activity. When combined with atropine or other anticholinergics, there is additive/synergistic blockade of muscarinic receptors, leading to exaggerated effects (urinary retention, dry mouth, constipation, confusion).

9. Darifenacin and solifenacin are more suitable for once-daily dosing in overactive bladder. Both have long half-lives allowing once-daily dosing. Darifenacin also has selectivity for M3 receptors in the bladder over M2 receptors in the heart, reducing cardiac side effects. Their pharmacokinetic profiles make them more patient-friendly than oxybutynin.

10. Atropine reduces gastric secretion but is less effective than H2 blockers. Atropine blocks only the muscarinic (M1/M3) component of gastric acid secretion. However, gastric acid secretion is also driven by histamine (H2 receptors) and gastrin, which atropine cannot block. H2 blockers inhibit a major and direct pathway of acid secretion, making them far more effective.

11. Atropine is contraindicated in elderly males with prostatic hypertrophy. Atropine relaxes the detrusor muscle and increases tone of the urinary sphincter (via M3 blockade), further reducing bladder contractility and increasing urinary outflow resistance. In elderly males with BPH, this can precipitate acute urinary retention.

12. Physostigmine is preferred over neostigmine in belladonna (atropine) poisoning. Physostigmine is a tertiary amine - it crosses the BBB and reverses both peripheral AND central muscarinic effects of atropine toxicity (CNS excitation, hallucinations, delirium). Neostigmine is a quaternary ammonium compound that cannot cross the BBB, so it only reverses peripheral effects.